Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Glioma is a common primary brain tumor with complex molecular mechanisms.
• Long noncoding RNAs (lncRNAs) play crucial roles in cancer progression.
• OIP5-AS1 has been implicated in various cancers, but its role in glioma requires further elucidation.

Purpose of the Study:

• To investigate the role of OIP5-AS1 in glioma progression.
• To explore the regulatory mechanism of OIP5-AS1 involving miR-410 and Wnt-7b.
• To assess the therapeutic potential of targeting OIP5-AS1 in glioma.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to measure gene expression in glioma tissues.
• Cell transfection with OIP5-AS1 siRNA and miR-410 inhibitors.
• Luciferase reporter assays to confirm targeting relationships.
• Western blotting for protein expression analysis.
• Cell proliferation, invasion, migration, cell cycle, and apoptosis assays (MTT, flow cytometry, Transwell, wound-healing).
• In vivo tumor growth inhibition studies.

Main Results:

• OIP5-AS1 was upregulated, while miR-410 was downregulated in glioma tissues.
• OIP5-AS1 directly targets miR-410, and miR-410 targets Wnt-7b.
• Silencing OIP5-AS1 inhibited glioma cell proliferation, invasion, and migration.
• OIP5-AS1 knockdown led to decreased expression of Wnt-7b and downstream proteins in the Wnt-7b/β-catenin pathway.
• Downregulation of OIP5-AS1 induced cell cycle arrest and apoptosis, and inhibited tumor growth in vivo.
• miR-410 inhibitors reversed the effects of OIP5-AS1 silencing.

Conclusions:

• OIP5-AS1 promotes glioma progression by sponging miR-410 and activating the Wnt-7b/β-catenin pathway.
• Targeting OIP5-AS1 represents a potential therapeutic strategy for glioma.
• The OIP5-AS1/miR-410/Wnt-7b axis is a critical regulator of glioma cell behavior.